We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baxter Warned About Mold, GMP Deviations at Two Plants
Baxter Warned About Mold, GMP Deviations at Two Plants
June 14, 2013
Problems handling mold and defects at two plants sparked an FDA request for Baxter International to take a hard look at its global manufacturing operations.